微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 14.32% | -17.56% | 52.18% | 4/52 | 3.3% | 澳洋健康 | 25.95% | 行业排名> |
| 2025-06-30 | 9.41% | 3.29% | 90.87% | 3/52 | 1.68% | 澳洋健康 | 19.74% | 行业排名> |
| 2025-03-31 | 4.93% | 5.57% | -68.38% | 3/52 | 0.99% | 澳洋健康 | 12.87% | 行业排名> |
| 2024-12-31 | 15.59% | -21.06% | -10.25% | 4/52 | -1.11% | 澳洋健康 | 28.53% | 行业排名> |
| 2024-09-30 | 17.37% | -2.63% | 90.67% | 3/52 | 3.33% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | 9.11% | -9.53% | 95.07% | 3/52 | 1.9% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | 4.67% | 2.19% | -76.35% | 3/52 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | 19.75% | -10.88% | 10.71% | 2/52 | 2.79% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 17.84% | -8.37% | 77.16% | 3/52 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 10.07% | -13.56% | 120.35% | 5/52 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 4.57% | -13.28% | -79.38% | 7/52 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | 22.16% | -10.1% | 13.82% | 7/52 | -1.81% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 19.47% | 3.18% | 67.12% | 9/52 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 11.65% | -0.77% | 121.06% | 10/52 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 5.27% | 10.02% | -78.62% | 9/52 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | 24.65% | -7.16% | 30.63% | 8/52 | -7.44% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | 18.87% | -13.64% | 60.73% | 6/52 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | 11.74% | 39.26% | 145.09% | 11/52 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2021-03-31 | 4.79% | 302.52% | -81.96% | 8/52 | 1.79% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-12-31 | 26.55% | 13.8% | 21.51% | 7/52 | 10.95% | 金域医学 | 13.23% | 行业排名> |
| 2020-09-30 | 21.85% | 8.49% | 159.19% | 4/52 | 7.83% | 万邦医药 | 52.05% | 行业排名> |
| 2020-06-30 | 8.43% | -27.7% | 608.4% | 10/52 | 2.48% | 华大基因 | 48.52% | 行业排名> |
| 2020-03-31 | 1.19% | -76.71% | -94.9% | 15/52 | -0.22% | 华大基因 | 31.24% | 行业排名> |
| 2019-12-31 | 23.33% | 17.53% | 15.84% | 9/52 | 65.31% | 阳光诺和 | 13.99% | 行业排名> |
| 2019-09-30 | 20.14% | 21.84% | 72.73% | 3/52 | 10.68% | *ST生物 | 2848.07% | 行业排名> |
| 2019-06-30 | 11.66% | 21.08% | 128.18% | 4/52 | 5.65% | *ST生物 | 98.98% | 行业排名> |
| 2019-03-31 | 5.11% | 25.55% | -74.26% | 6/52 | 3.54% | *ST生物 | 82.46% | 行业排名> |
| 2018-12-31 | 19.85% | -12.63% | 20.08% | 10/52 | -0.6% | *ST生物 | 48.41% | 行业排名> |
| 2018-09-30 | 16.53% | -20.8% | 71.65% | 5/52 | 2.62% | 万邦医药 | 106.72% | 行业排名> |
| 2018-06-30 | 9.63% | -21.58% | 136.61% | 4/52 | 1.51% | 国际医学 | 46.66% | 行业排名> |
| 2018-03-31 | 4.07% | -21.58% | -82.09% | 4/52 | 0.52% | 普蕊斯 | 22.99% | 行业排名> |
| 2017-12-31 | 22.72% | 6.07% | 8.86% | 4/52 | 1.73% | 通策医疗 | 6.02% | 行业排名> |
| 2017-09-30 | 20.87% | 11.54% | 69.95% | 1/52 | 8.61% | 普蕊斯 | 58.68% | 行业排名> |
| 2017-06-30 | 12.28% | 15.52% | 136.61% | 4/52 | 60.47% | 爱尔眼科 | 20.87% | 行业排名> |
| 2017-03-31 | 5.19% | 8.35% | -75.77% | 1/52 | -5.59% | *ST生物 | 1666.98% | 行业排名> |
| 2016-12-31 | 21.42% | 1.37% | 14.48% | 8/52 | 23.06% | 爱尔眼科 | 5.19% | 行业排名> |
| 2016-09-30 | 18.71% | 10.45% | 76.01% | 3/52 | 5.93% | *ST生物 | 383.03% | 行业排名> |
| 2016-06-30 | 10.63% | 7.7% | 121.92% | 4/52 | 4.57% | *ST宜康 | 36.84% | 行业排名> |
| 2016-03-31 | 4.79% | 12.18% | -77.33% | 3/52 | 1.51% | 药石科技 | 24.53% | 行业排名> |